Results of a small clinical trial suggest that pycnogenol may provide some benefit for people suffering from Restless Legs Syndrome (RLS), a difficult-to-manage condition associated with increased cardiovascular risk. In a non-blinded and non-randomized trial, otherwise healthy adults with RLS (mean age 44) were given either 150mg pycnogenol per day (n=21) along with standard therapy…